Praxis Precision Medicines (PRAX) Misses Q2 EPS by 6c

Praxis Precision Medicines (NASDAQ: PRAX) reported Q2 EPS of ($3.31), $0.06 worse than the analyst estimate of ($3.25).

For earnings history and earnings-related data on Praxis Precision Medicines (PRAX) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• BNP Paribas Exane Upgrades Novonesis A/S (NSISB:DC) to Neutral
• Morgan Stanley Downgrades Repsol SA (REP:SM) (REPYY) to Equalweight